首页 >
法规速递
-
Document: Respiporc Flu3 : EPAR - All Authorised presentations-2025/10/14
2025-10-15查看详情 > -
Document: EMA health threats plan - Annex 1: Acceleration of regulatory procedures during public health emergencies-2025/11/18
2025-11-19查看详情 > -
Page: Union list of critical medicines-2025/12/12
2025-12-15查看详情 > -
深化改革 强化监管 切实保障药品高水平安全-2026/1/27
2026-01-28查看详情 > -
Document: Draft guidance on the conduct of clinical trials during public health emergencies-2026/3/4
2026-03-05查看详情 > -
Document: Records of data processing activity for the Union Product Database-2026/4/1
2026-04-02查看详情 > -
Document: Highlights from the second expert panels and notified bodies workshop-2026/5/18
2026-05-19查看详情 > -
国家药监局关于化学原料药适用药品上市许可优先审评审批工作程序有关事宜的通告（2026年第25号）-2026/7/1
2026-07-02查看详情 > -
Page: Medicine shortages and availability issues: guidance for companies-2026/8/7
2026-08-09查看详情 > -
国家药监局关于医用透明质酸钠产品管理类别的公告（2022年第103号）-2022/11/14
2022-11-30查看详情 >
